Impact of COVID-19 Telehealth Policy Changes on Access to Medication Treatment for Patients with Opioid Use Disorder

November 22, 2022


Read time:

5-15 mins
Telehealth 03 Web Main 0 1200x700

Telehealth has played a significant role in maintaining and increasing access to buprenorphine treatment for individuals with opioid use disorder during the COVID-19 pandemic, according to a new University of Michigan study. The research team studied how pandemic-related policy changes in March 2020 affected buprenorphine treatment across audio-only, video, and in-person visit types. The research team shares additional takeaways from the study and highlights from their work.

More from the Alumni Education Gateway
Join the Alumni Education Gateway Email List​
We use cookies to ensure you get the best experience on our website. By using this site, you accept our use of cookies.